Can Biologics Be Discontinued in Patients with Psoriatic Arthritis in Stable Remission? A Prospective Single-CenterClinical and Ultrasound Study

Table 4

Psoriasis comorbidities on TP0 (baseline) vs TP1 (disease relapse).

		TP1 (disease relapse)		McNemar test
		No	Yes	value
		N (%)	N (%)
TP0 (baseline)
COPD	No	44 (97.8)	1 (2.2)	0.999
	Yes	0 (0.0)	0 (0.0)
Ischemic heart disease	No	40 (100.0)	0 (0.0)	0.999
	Yes	0 (0.0)	5 (100.0)
Depression	No	42 (100.0)	0 (0.0)	0.999
	Yes	1 (33.3)	2 (66.7)
Type II diabetes	No	38 (100.0)	0 (0.0)	0.999
	Yes	0 (0.0)	7 (100.0)
Dyslipidemia	No	36 (100.0)	0 (0.0)	0.999
	Yes	0 (0.0)	9 (100.0)
Ultrasound carotid plaque	No	40 (100.0)	0 (0.0)	0.999
	Yes	1 (20.0)	4 (80.0)
Ultrasound nonalcoholic fatty liver	No	25 (92.6)	2 (7.4)	0.999
	Yes	1 (5.5)	17 (94.5)
Hypertension	No	26 (96.3)	1 (3.7)	0.999
	Yes	1 (5.5)	17 (94.5)
Obesity	No	34 (94.6)	2 (5.4)	0.500
	Yes	0 (0.0)	9 (100.0)
Psoriasis onychopathy	No	36 (85.7)	6 (14.3)	0.031
	Yes	0 (0.0)	3 (100.0)
Autoimmune thyroiditis	No	44 (100.0)	0 (0.0)	0.999
	Yes	0 (0.0)	1 (100.0)
Peripheral arterial disease	No	44 (100.0)	0 (0.0)	0.999
	Yes	0 (0.0)	1 (100.0)

Bold values represent statistically significant results.